CVS - CVS Health Corp - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CVS is currently covered by 21 analysts with an average price target of $91.26. This is a potential upside of $20.44 (28.86%) from yesterday's end of day stock price of $70.82.

CVS Health Corp's activity chart (see below) currently has 439 price targets and 392 ratings on display. The stock rating distribution of CVS is 70.59% BUY and 29.41% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 51.24% with an average time for these price targets to be met of 609.7 days.

Highest price target for CVS is $84, Lowest price target is $62, average price target is $76.16.

Most recent stock forecast was given by ERIC COLDWELL from BAIRD on 14-Aug-2025. First documented stock forecast 01-May-2013.

Currently out of the existing stock ratings of CVS, 60 are a BUY (70.59%), 25 are a HOLD (29.41%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$82

$13.4 (19.53%)

$110

6 days ago
(14-Aug-2025)

5/8 (62.5%)

$15.27 (22.88%)

639

Hold

$67

$-1.6 (-2.33%)

$62

29 days ago
(22-Jul-2025)

10/14 (71.43%)

$5.92 (9.69%)

882

Buy

$80

$11.4 (16.62%)

$95

1 months 21 days ago
(30-Jun-2025)

8/12 (66.67%)

$11.02 (15.98%)

686

Buy

$79

$10.4 (15.16%)

$82

2 months 18 days ago
(02-Jun-2025)

3/9 (33.33%)

$15.4 (24.21%)

108

Buy

$84

$15.4 (22.45%)

$82

3 months 8 days ago
(12-May-2025)

7/18 (38.89%)

$19.19 (29.61%)

378

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CVS (CVS Health Corp) average time for price targets to be met?

On average it took 609.7 days on average for the stock forecasts to be realized with a an average price target met ratio 51.24

Which analyst has the current highest performing score on CVS (CVS Health Corp) with a proven track record?

LANCE WILKES

Which analyst has the most public recommendations on CVS (CVS Health Corp)?

Lance Wilkes works at BERNSTEIN and has 15 price targets and 6 ratings on CVS

Which analyst is the currently most bullish on CVS (CVS Health Corp)?

Ivan Feinseth with highest potential upside - $61.4

Which analyst is the currently most reserved on CVS (CVS Health Corp)?

Andrew Wolf with lowest potential downside - -$23.6

CVS Health Corp in the News

Is CVS a Smart Buy Now on Strong Q2, Low Valuation & Long-Term Upside?

Investors responded with optimism following CVS Health’s CVS second-quarter 2025 earnings release last week, buoyed by better-than-expected earnings and revenue growth, improved segment performance and an upward revision to full-year guidance, reflecting operational momentum in its Health Care Benefits and Pharmacy & Consumer Wellness segments. This, coupled with a strong year-to-date cash flow of $6.5...

CVS Health beats second quarter expectations, raises full-year profit outlook

Investing.com — CVS Health Corporation reported second-quarter earnings that surpassed analyst expectations on Friday. Adjusted earnings per share came in at $1.81, significantly above the consensus estimate of $1.46. Revenue for the quarter reached $98.9 billion, exceeding analyst projections of $94.73 billion and representing an 8.4% increase YoY. The healthcare giant raised its full-year adjusted...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?